An enigmatic type of circulating tumor cell called a dual-positive cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine.
Back to News
Weill Cornell MedicineOffice of External Affairs Phone: (646) 962-9476